COS Uptake and Endorsement

It is important to assess the uptake and use of COS in clinical trials, and other research, in order to avoid the development of these COS contributing to the research waste which their development aims to reduce. Assessing uptake can also highlight the benefits of measuring and reporting COS in trials while allowing review and feedback to ensure ongoing relevance, and removal of barriers and facilitators to uptake. A collection of Podcasts highlight the importance of the development and use of COS to people from a range of different backgrounds.

The following organisations actively endorse the use of COS and the COMET database.

Trialists

• SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
   

Trial Funders

• ZonMw
• National Institute for Health Research (NIHR), UK:Guidance Notes For Completing Full Proposals
• Horizon2020:
• http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-pm-10-2017.html
• Deutsche Forschungsgemeinschaft (DFG) German Research Foundation
• Proposal Preparation Instructions: Clinical Trials Programme – Draft Proposals
• Proposal Preparation Instructions: Clinical Trials Programme – Full Proposals
• Arthritis Research UK (ARUK)
• Health Research Board (HRB)
• KCE: Belgian Health Care Knowledge Centre

Trial Registries

• ISRCTN

Regulatory Authorities

• European Medicines Agency
• Health Research Authority (HRA, UK)

Systematic Review Groups

• Cochrane Collaboration
• CSG-COUSIN

Clinical Guideline Development Groups

• National Institute for Health and Care Excellence

Journal Editors

• http://www.crown-initiative.org/

Other

• European Federation of Pharmaceutical Industries and Associations
• Association of Medical Research Charities (AMRC)- http://www.amrc.org.uk/blog/how-can-the-charity-perspective-shape-guidance-on-core-outcomes-for-clinical-research
• Center for Medical Technology Pollicy (CMTP)

COS Collaborative Groups

• Outcome Measures in Rheumatology (OMERACT)
• Harmonizing Outcome Measures for Eczema (HOME)
• European Wound Management Association Patient Outcome Group (EWMA)
• International Myositis Assessment and Clinical Studies Group (IMACS)
• Pediatric Rheumatology International Trials Organization (PRINTO)
• Core Outcomes in Women s Health (CROWN)
• International Collaboration to harmonise Outcomes for Pre-eclampsia (iHOPE)
• The Cochrane Skin Group Outcomes Research Initiative (CSG-COUSIN)
• GAStric cancer Trials Reported Outcomes Standardisation (GASTROS)
• Improving Long-Term Outcomes Research for Acute Respiratory Failure
• Standardised Outcomes in NephroloGy (SONG)
• Core outcomes and common data elements for cervical degenerative myelopathy (CODE-CDH)
• Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT)
• ICF Research Branch
• European Society of Cutaneous Lupus Erythematosus (EUSCLE)
• Acute Dialysis Quality Initiative (ADQI)
• Prevention of Falls Network (PROFANE)
• Women and Babies Health and Wellbeing : Action through Trials (WOMBAT)
• Improving Long-Term Outcomes Research for Acute Respiratory Failure (IMPROVELTO)